Physician profile
Devoni Jorgensen Bruns
NPI 1154859973
$1,437.34
in general payments reported to CMS, 2019-2025
17 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $11.95 · 2022: $46.99 · 2023: $344 · 2024: $593 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $330.77 | 2019-2025 | |
| Amgen INC. | $242.41 | 2023-2025 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $115.86 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $98.61 | 2024-2025 | Myfembree |
| Organon LLC | $97.33 | 2024 | |
| Shield Therapeutics INC | $80.00 | 2024 | |
| Becton, Dickinson and Company | $79.01 | 2023 | Bd Max System, Bd Max Instrument |
| Hologic Sales and Service, LLC | $62.33 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $59.94 | 2023-2024 | Slynd |
| Astellas Pharma US INC | $58.29 | 2025 | Veozah |
| Pfizer INC. | $44.51 | 2024 | |
| Biogen, INC. | $39.73 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $39.01 | 2024-2025 | Paragard T 380a |
| Dexcom, INC. | $36.50 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $22.36 | 2023 | Gardasil 9 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.73 | 2023 | Cologuard Collection Kit |
| Boston Scientific Corporation | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devoni Bruns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.